The goal is to introduce the water as peacefully as possible
Serious adverse effects requiring monitoring include: Hypoglycemia : While GLP-1 receptor agonists have low intrinsic hypoglycemia risk due to glucose-dependent mechanisms, risk increases with concomitant insulin or sulfonylurea use
However, Vash says, that's a very rare side effect. And if youve heard that GLP-1s can increase your risk of thyroid cancer, you dont necessarily need to be alarmed
1 Introduction The use of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) has revolutionized the treatment of Type 2 Diabetes Mellitus (T2DM)
Assessed as up to date in November 2024 by Tessy Boedt
Retrieved May 6, 2025, from National Institutes of Health, Office of Dietary Supplements